<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>贝壳社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-02T20:33:12+08:00</updated>
  <subtitle>贝壳社是国内领先的医疗健康创新创业服务平台，集聚政府、上市公司、投资机构和三甲医院等产业高端资源，提供一站式的全球生命健康人才项目引进、转化孵化和产业化等全产业链协同创新和赋能服务。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“心”之所向，新赛道大市场——论心脏瓣膜市场发展现状及未来空间【器械系列深度】</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/OtpWQ6-adgvSQ_gvhzakLA</id>
    <link href="https://mp.weixin.qq.com/s/OtpWQ6-adgvSQ_gvhzakLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有效率超过94%，Moderna已向FDA申请紧急使用授权，预计本月底将交付</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/cMf8E2Ba02CWFnYi4DUZvw</id>
    <link href="https://mp.weixin.qq.com/s/cMf8E2Ba02CWFnYi4DUZvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DeepMind AI 解决生物学50年来重大挑战，破解蛋白质分子折叠问题</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/OvAcdNZJ7cNiVVCa4qsVfQ</id>
    <link href="https://mp.weixin.qq.com/s/OvAcdNZJ7cNiVVCa4qsVfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服FGFR抑制剂获FDA优先审评资格，治疗胆管癌；科研不端行为将“一票否决” | 贝壳日报</title>
    <updated>2020-12-02T17:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/R5410FY6BE9fFT-PaJte1g</id>
    <link href="https://mp.weixin.qq.com/s/R5410FY6BE9fFT-PaJte1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T治疗实体瘤再迈一小步，背后是这家细胞疗法实力“猛将”</title>
    <updated>2020-12-01T17:38:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/O2uunIXBCnCJ-j3o8m0GVg</id>
    <link href="https://mp.weixin.qq.com/s/O2uunIXBCnCJ-j3o8m0GVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝壳圈 | 2020年11月</title>
    <updated>2020-12-01T17:38:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/k1kYcsM6aN-z2GaHYX5VtQ</id>
    <link href="https://mp.weixin.qq.com/s/k1kYcsM6aN-z2GaHYX5VtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索元生物获得抗癌新药重组人血管内皮抑素，核心产品管线拓展至大分子生物药领域</title>
    <updated>2020-12-01T17:38:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/PrOiDdI2Aml9L9lqn8v3UA</id>
    <link href="https://mp.weixin.qq.com/s/PrOiDdI2Aml9L9lqn8v3UA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HER2靶向双特异性抗体获FDA突破性疗法认定，治疗特定胆道癌患者；湖南发布免试村医实施细则 | 贝壳日报</title>
    <updated>2020-12-01T17:38:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/qehqlNPSWqTNvorJxVJS2Q</id>
    <link href="https://mp.weixin.qq.com/s/qehqlNPSWqTNvorJxVJS2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚，贝壳社、青蓝港湾与舟山普陀区政府达成两项重磅合作！</title>
    <updated>2020-11-30T15:44:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/AvcwvBnP08KA-Cc3iOdYlA</id>
    <link href="https://mp.weixin.qq.com/s/AvcwvBnP08KA-Cc3iOdYlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>31亿美元开发突破性抑郁症和运动障碍疗法，渤健达成研发合作；首个治疗特定基因缺陷引起的肥胖症新药获FDA批准 | 贝壳日报</title>
    <updated>2020-11-30T15:44:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/PkvEfL7wgqd6rJdQfQhviw</id>
    <link href="https://mp.weixin.qq.com/s/PkvEfL7wgqd6rJdQfQhviw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞、信达、君实、百济PD-1谁的销量高？谁能取胜药价谈判？谁的适应症多？谁进治疗指南多？PD-(L)1价格战已在途！</title>
    <updated>2020-11-27T20:15:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Z-1DPv_OYKlOuM1epkNClQ</id>
    <link href="https://mp.weixin.qq.com/s/Z-1DPv_OYKlOuM1epkNClQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来、辉瑞、罗氏纷纷布局，基因疗法能否为这种罕见病带来曙光？</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/4_OfUNygw49Sk-gIVZ7yvQ</id>
    <link href="https://mp.weixin.qq.com/s/4_OfUNygw49Sk-gIVZ7yvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>581天同行：在变化中成长，在坚持中蜕变 | 贝壳大学三期毕业典礼圆满召开</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Y-O7Wp62Dqm7AwLyU-zx4g</id>
    <link href="https://mp.weixin.qq.com/s/Y-O7Wp62Dqm7AwLyU-zx4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干细胞治疗新冠相关呼吸疾病，诺华达成13.5亿美元协议；医院发布：限制非基药使用 | 贝壳日报</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/BKYJ4PE1G2zrjNfixMeZMQ</id>
    <link href="https://mp.weixin.qq.com/s/BKYJ4PE1G2zrjNfixMeZMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三代试管婴儿法规监管里程碑：首个“有证”PGS试剂盒亮相中华医学会2020生殖医学年会</title>
    <updated>2020-11-26T09:47:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/0tYBVLycC8xhWBV0r5rfRQ</id>
    <link href="https://mp.weixin.qq.com/s/0tYBVLycC8xhWBV0r5rfRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向p53突变，潜在新药启动临床试验；Ebiomedicine: 新研究有助于治疗炎症反应 | 贝壳日报</title>
    <updated>2020-11-26T09:47:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/LTS2c7IaNgBlLpuPXDQyTA</id>
    <link href="https://mp.weixin.qq.com/s/LTS2c7IaNgBlLpuPXDQyTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>启动“细胞药物研发生产基地”，牵手基因与细胞治疗CDMO龙头，羿尊生物驶入发展快车道</title>
    <updated>2020-11-25T11:19:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/hMpeUYzL_Duzk2kb0yLomg</id>
    <link href="https://mp.weixin.qq.com/s/hMpeUYzL_Duzk2kb0yLomg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个早衰症治疗药物获FDA批准，死亡率降低77％；圣和药业丙肝1类新药拟纳入优先审评 | 贝壳日报</title>
    <updated>2020-11-25T11:19:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/D7N8gjB2cn2OfgYLBJLnnA</id>
    <link href="https://mp.weixin.qq.com/s/D7N8gjB2cn2OfgYLBJLnnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TAVR在美国的发展现状</title>
    <updated>2020-11-24T17:23:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/cOq_1m7HK5o2Yph1EOr64Q</id>
    <link href="https://mp.weixin.qq.com/s/cOq_1m7HK5o2Yph1EOr64Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和铂医药通过港交所聆讯，多产品线拓展，六项进入临床阶段</title>
    <updated>2020-11-24T17:23:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/D1P31UZyOgOdIRF9lX-9fg</id>
    <link href="https://mp.weixin.qq.com/s/D1P31UZyOgOdIRF9lX-9fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>